ClinicalTrials.gov
public full text
Public Domain
Alternatives for Reducing Tics in Tourette Syndrome (TS): A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents
This is a study to evaluate the efficacy and safety of deutetrabenazine (TEV-50717) tablets for the reduction of motor and phonic tics associated with TS in children and adolescents 6 through 16 years of age.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Developing Cognitive Training for Tourette Syndrome#825182
- Median Nerve Stimulation for Tourette Syndrome and Chronic Tic Disorder#893681
- Benzamide Derivates as Treatment of Clozapine-induced Hypersalivation#829987
- Anger Control Training for Youth With Tourette Syndrome#994425
- A Study of Levetiracetam in Japanese Pediatric Patients With Generalized Tonic-clonic Seizures#916471
Record · ID 811342
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive